Wolbachia-carrying Aedes mosquitoes for preventing dengue infection
Tilly Fox,Yanina Sguassero,Marty Chaplin,Winsley Rose,Dyna Doum,Ingrid Arevalo-Rodriguez,Gemma Villanueva
DOI: https://doi.org/10.1002/14651858.cd015636.pub2
IF: 8.4
2024-04-12
Cochrane Database of Systematic Reviews
Abstract:Dengue is a global health problem of high significance, with 3.9 billion people at risk of infection. The geographic expansion of dengue virus (DENV) infection has resulted in increased frequency and severity of the disease, and the number of deaths has increased in recent years. Wolbachia ,an intracellular bacterial endosymbiont, has been under investigation for several years as a novel dengue‐control strategy. Some dengue vectors ( Aedes mosquitoes) can be transinfected with specific strains of Wolbachia, which decreases their fitness (ability to survive and mate) and their ability to reproduce, inhibiting the replication of dengue. Both laboratory and field studies have demonstrated the potential effect of Wolbachia deployments on reducing dengue transmission, and modelling studies have suggested that this may be a self‐sustaining strategy for dengue prevention, although long‐term effects are yet to be elucidated. To assess the efficacy of Wolbachia ‐carrying Aedes speciesdeployments (specifically w Mel ‐ , w MelPop ‐ , and w AlbB‐ strains of Wolbachia ) for preventing dengue virus infection. We searched CENTRAL, MEDLINE, Embase, four other databases, and two trial registries up to 24 January 2024. Randomized controlled trials (RCTs), including cluster‐randomized controlled trials (cRCTs), conducted in dengue endemic or epidemic‐prone settings were eligible. We sought studies that investigated the impact of Wolbachia‐ carrying Aedes deployments on epidemiological or entomological dengue‐related outcomes, utilizing either the population replacement or population suppression strategy. Two review authors independently selected eligible studies, extracted data, and assessed the risk of bias using the Cochrane RoB 2 tool. We used odds ratios (OR) with the corresponding 95% confidence intervals (CI) as the effect measure for dichotomous outcomes. For count/rate outcomes, we planned to use the rate ratio with 95% CI as the effect measure. We used adjusted measures of effect for cRCTs. We assessed the certainty of evidence using GRADE. One completed cRCT met our inclusion criteria, and we identified two further ongoing cRCTs. The included trial was conducted in an urban setting in Yogyakarta, Indonesia. It utilized a nested test‐negative study design, whereby all participants aged three to 45 years who presented at healthcare centres with a fever were enrolled in the study provided they had resided in the study area for the previous 10 nights. The trial showed that w Mel‐ Wolbachia infected Ae aegypti deployments probably reduce the odds of contracting virologically confirmed dengue by 77% (OR 0.23, 95% CI 0.15 to 0.35; 1 trial, 6306 participants; moderate‐certainty evidence). The cluster‐level prevalence of w Mel Wolbachia‐ carrying mosquitoes remained high over two years in the intervention arm of the trial, reported as 95.8% (interquartile range 91.5 to 97.8) across 27 months in clusters receiving w Mel‐ Wolbachia Ae aegypti deployments, but there were no reliable comparative data for this outcome. Other primary outcomes were the incidence of virologically confirmed dengue, the prevalence of dengue ribonucleic acid in the mosquito population, and mosquito density, but there were no data for these outcomes. Additionally, there were no data on adverse events. The included trial demonstrates the potential significant impact of w Mel‐ Wolbachia‐ carrying Ae aegypti mosquitoes on preventing dengue infection in an endemic setting, and supports evidence reported in non‐randomized and uncontrolled studies. Further trials across a greater diversity of settings are required to confirm whether these findings apply to other locations and country settings, and greater reporting of acceptability and cost are important. Key messages – People living in areas where Wolbachia ‐carrying Aedes mosquitoes have been released are less likely to contract dengue than people living in areas with no release. – People living in areas where Wolbachia ‐carrying Aedes mosquitoes have been released are less likely to be admitted to hospital due to dengue than people living in areas with no release. What is dengue? Dengue is a viral disease transmitted by certain mosquitoes that is found in over 100 countries, with 3.9 billion people at risk of infection. Most dengue infections are mild (fever, headache, and muscle and joint pain), and some people do not have symptoms, but 1 in 20 people will develop a severe form of dengue. In the worst cases, this can cause organ failure and be life‐threatening. Therefore, preventing the spread of dengue virus is of high importance. What is Wolbachia, and how could these bacteria prevent dengue? Wolbachia is a bacterium that can infect mo -Abstract Truncated-
medicine, general & internal